12.09.25 -- Can Digital Endpoints Really Accelerate Clinical Trials?

Learn the distinctions between a Waiver of Consent and a Waiver of Written Consent in clinical trials and the importance of informed consent, particularly in the context of virtual trials.

Explore how integrating eCOA, wearables, and AI-driven technologies can transform your vaccine trials for greater efficiency, patient engagement, and data quality.

A platform automates case report form and edit check development, removes common review bottlenecks, and accelerates validation and testing while maintaining strong data quality from the start.

Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.

See how sponsors of Huntington’s disease (HD) clinical trials can potentially obtain earlier indications of progress by utilizing digital biomarkers.

Examine the benefits of a site-first approach to technology and consider how these tools are able to empower sites with integrated workflows that can change the clinical trial process.

CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.